Loading provider…
Loading provider…
Gastroenterology Physician in Saint Louis, MO
NPI: 1285628511Primary Practice Location
BARNES JEWISH HOSPITAL
1 Barnes Jewish Hospital Plz, Saint Louis, MO
Primary Employer
Washington University School of Medicine
surgery.wustl.edu
HQ Phone
Get MD Richard's Phone Numberphone_androidMobile
Get MD Richard's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMO State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 74 | 147 |
| 2 | 45380Biopsy of the large bowel using an endoscope (colonoscopy) | 20 | 20 |
| 3 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 17 | 17 |
| 4 | 43239Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | 14 | 15 |
| 5 | 99215Established patient office or other outpatient, visit typically 40 minutes | 12 | 12 |
Authors: Anas Gremida, Matthew Ciorba, Parakkal Deepak, Siyan Cao, Martin Gregory, Alexandra Gutierrez, Chien-Huan Chen, Rodney Newberry, Deborah Rubin, Xiaotang Du
Journal: Gastroenterology
Publication Date: 2024-07-30
Authors: Aava Khatiwada, Anas Gremida, Quazim Alayo, Matthew Ciorba, Parakkal Deepak, Alexandra Gutierrez, Maria Zulfiqar
Journal: Inflamm Bowel Dis
Authors: Anas Gremida, Matthew Ciorba, Parakkal Deepak, Martin Gregory, Carlos Mejia Chew, Andrej Spec
Journal: Crohns Colitis 360
Publication Date: 2023-02-19
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo SC, DRUG: Mirikizumab SC, DRUG: Mirikizumab IV
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Placebo, DRUG: Mirikizumab
Lead Sponsor: Eli Lilly and Company
Intervention / Treatment: DRUG: Mirikizumab